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While the biological roles of canonical Wnt/b-
catenin signaling in development and disease
are well documented, understanding the mo-
lecular logic underlying the functionally distinct
nuclear transcriptional programs mediating the
diverse functions of b-catenin remains a major
challenge. Here, we report an unexpected strat-
egy for b-catenin-dependent regulation of cell-
lineage determination based on interactions
between b-catenin and a specific homeodo-
main factor, Prop1, rather than Lef/Tcfs. b-cat-
enin acts as a binary switch to simultaneously
activate expression of the critical lineage-deter-
mining transcription factor, Pit1, and to repress
the gene encoding the lineage-inhibiting tran-
scription factor, Hesx1, acting via TLE/Reptin/
HDAC1 corepressor complexes. The strategy
of functionally distinct actions of a homeodo-
main factor in response to Wnt signaling is sug-
gested to be prototypic of a widely used mech-
anism for generating diverse cell types from
pluripotent precursor cells in response to com-
mon signaling pathways during organogenesis.
INTRODUCTION
Among evolutionarily conserved signaling pathways, the
pleiotropic effects of Wnt/b-catenin signaling functionsare well established in biological processes including em-
bryogenesis, tumorigenesis, and stem cell biology (Cadi-
gan and Nusse, 1997; Dorsky et al., 1998; Hill et al.,
2005; Huelsken et al., 2001; Kleber and Sommer, 2004;
Lee et al., 2004; Logan and Nusse, 2004; Pinto et al.,
2003; Reya et al., 2003; Tao et al., 2005; van de Wetering
et al., 2002; Zechner et al., 2003; Murtaugh et al., 2005;
Hari et al., 2002). Activation of the canonical Wnt/b-catenin
pathway stabilizes b-catenin protein levels, allowing relo-
cation of b-catenin to the nucleus, where it serves as
a coactivator of the Lef/Tcf DNA binding factors, dis-
placing HDAC and TLE corepressor complexes (Behrens
et al., 1996; Billin et al., 2000; Cavallo et al., 1998; Daniels
and Weis, 2005; Molenaar et al., 1996; van de Wetering
et al., 1997) and recruiting coactivators p300/CBP
(Hecht et al., 2000) and Brg1 for chromatin remodeling
(Barker et al., 2001). Many proteins are associated with
cytoplasmic b-catenin for regulation of Wnt/b-catenin
pathway activities (Nelson and Nusse, 2004; Peifer and
Polakis, 2000), but the Lef/Tcf family of transcription fac-
tors remain the sole focus as unambiguous DNA binding
partners for the diverse b-catenin-dependent nuclear tran-
scription programs (Clevers and van de Wetering, 1997;
Giles et al., 2003). Therefore, understanding whether addi-
tional transcriptional strategies are required to achieve the
pleiotropic effects of the Wnt/b-catenin signaling pathway
remains of major interest.
The development of the anterior pituitary gland provides
an ideal model system for investigating signaling functions
because it sequentially progresses from a primordium of
pluripotent ectodermal cells to a complex organ containing
five distinct hormone-producing cell types: corticotropes,Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc. 593
Figure 1. Temporal Control of Wnt/b-Catenin Signaling in Pituitary Development
(A) Axin2 expression (white signal by in situ hybridization) in the anterior pituitary gland during the specific E11.5–E14.5 developmental window and
dynamic Lef1 expression at E9.0 in the presumptive Rathke’s pouch (RP) epithelium, which is then extinguished from RP until E13.5 but reappears in
a restricted caudomedial domain of the anterior pituitary (arrowhead).
(B) Chromatin immunoprecipitation (ChIP) on E12.5 and E13.5 pituitary glands using specific b-catenin, acetylated histone H3, and Tcf4 antibodies,
indicating binding to Wnt-responsive elements in the Axin2 and Lef1 promoters.594 Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc.
lactotropes, somatotropes, thyrotropes, and gonado-
tropes. Early pituitary development at E9.0–E9.5 requires
dorsal-ventral signals such as Sonic hedgehog, Fgf8/10,
and Bmp4 and involves the actions of several homeodo-
main transcription factors expressed before or during the
initial invagination of oral ectoderm that creates Rathke’s
pouch (Dasen and Rosenfeld, 2001; Scully and Rosenfeld,
2002; Watkins-Chow and Camper, 1998). Later generation
of somatotrope, lactotrope, and thyrotrope cell types de-
pends on the function of a tissue-specific POU-class ho-
meodomain transcription factor, Pit1 (Li et al., 1990). The
expression of Pit1 is positively regulated by a paired-like
homeodomain transcription factor, Prophet of Pit1
(Prop1) (Gage et al., 1996; Sornson et al., 1996) and nega-
tively regulated by a second, highly related,paired-like fac-
tor, Hesx1/Rpx (Hermesz et al., 1996; Martinez-Barbera
et al., 2000), which recruits Groucho/TLE and N-CoR core-
pressors (Dasen et al., 2001).
Here, we report a strategy by which the Wnt/b-catenin
pathway provides a key signal for determining cell line-
ages during pituitary development, with direct interactions
between b-catenin and the tissue-specific homeodomain
factor Prop1, rather than Lef/Tcfs, serving as the mecha-
nism for transcriptional activation of the Pit1 gene. A
Prop1/b-catenin complex simultaneously represses ex-
pression of the Hesx1 paired-like homeodomain factor
via recruitment of TLE/Groucho, HDACs, and Reptin. To-
gether, these results establish a transcriptional switching
mechanism for b-catenin control of cell-fate determination
based on the actions of Prop1/b-catenin in both gene ac-
tivation and gene repression.
RESULTS
Temporal Regulation of Wnt/b-Catenin Activity
Dictates a Specific Pituitary Cell Lineage
Specific members of the Lef/Tcf transcription-factor fam-
ily exhibited distinct pituitary-specific expression pat-
terns, with Lef1 reappearing at E13.5 in the anterior gland
following initial transient expression at E9.0 (Figure 1A).
Tcf3 and Tcf4 were expressed during early stages of or-
gan patterning but did not overlap with the initiation of
Lef1 and Pit1 expression at E13.5 (see Figure S1A in the
Supplemental Data available with this article online), sug-
gesting distinct and nonoverlapping roles with respect to
Lef1. Tcf1 expression was negligible in Rathke’s pouch.
Ten of the nineteen murine Wnt genes were present
in the developing E12.5 pituitary by semiquantitativeRT-PCR analyses (Figure S1C). The Wnt target Axin2
(Aulehla et al., 2003; Jho et al., 2002) was expressed be-
tween E11.5 and E15.5 (Figure 1A), suggesting a tempo-
rally specific function of the Wnt-signaling pathway during
pituitary organogenesis. Indeed, chromatin immunopre-
cipitation on microdissected Rathke’s pouches at E12.5
revealed that b-catenin protein was associated with Lef/
Tcf binding regions in the Axin2 promoter (Aulehla et al.,
2003; Jho et al., 2002) (Figure 1B) and with a Wnt-respon-
sive element conserved in the mouse/human Lef1 pro-
moter (Filali et al., 2002) at E13.5 (Figure 1B), providing
direct evidence of transcriptional activity of the Wnt/
b-catenin pathway during pituitary development.
We generated two Cre-expressing transgenic lines,
Pitx1/Cre and Pit1/Cre, to modulate canonical Wnt/b-cat-
enin signaling-pathway activity by controlling expression
of b-catenin using a Cre/LoxP genetic strategy. Crossing
with R26R lacZ reporter mice (Soriano, 1999) revealed
that the Pitx1/Cre transgene, controlled by the 8 kb
Pitx1 promoter (Dasen et al., 2001; Treier et al., 1998), ex-
hibited efficient Cre-recombinase activity starting at E9.0
in all progenitors of Rathke’s pouch that give rise to every
cell type of the mature pituitary gland (Figure 1C, and
Figure S1C), while Pit1/Cre, controlled by the 15 kb
Pit1 promoter (Rhodes et al., 1993; Treier et al., 1998), ex-
hibited efficient Cre-recombinase activity only in the Pit1
lineage starting at E13.5 (data not shown). The Pitx1/Cre
and Pit1/Cre transgenic mice were then crossed with con-
ditionally active or inactive b-catenin mouse lines: The b-
catenin/loxP(ex2-6) line deletes critical b-catenin coding
exons and consequently knocks out the Wnt/b-catenin
pathway after Cre-dependent recombination (Brault
et al., 2001), while the b-catenin/loxP(ex3) line generates
a stable form of b-catenin protein, thereby leading to
a constitutively active Wnt/b-catenin pathway after Cre re-
combination (Harada et al., 1999) (Figure 1C). The effi-
ciency of these genetic approaches was verified directly
by assaying b-catenin protein levels (Figure 1C). The po-
tential roles of b-catenin could then be examined with re-
spect to various transcription factors expressed in tempo-
rally specific patterns during pituitary organogenesis
(Figure 1D).
Following early loss of b-catenin function due to Pitx1/
Cre, the embryos exhibited relatively normal early pituitary
development with only subtle morphological defects
and a smaller gland along the lateral axis (Figure 2A),
with unaltered expression of early homeodomain factors
Lhx3, Hesx1, Pitx2, Isl1, and Msx1 from E9.5 to E11.5 (Fig-
ures 2A–2C and data not shown). Unexpectedly, Pit1 gene(C) Conditional b-catenin alleles for generating tissue-specific constitutively active (CA-Cat) (Harada et al., 1999) and knockout (KO-Cat) (Brault et al.,
2001) forms of b-catenin. Activity of Pitx1/Cre transgene precedes the lineage of all cells of the pituitary gland at E14.5 as assayed by analysis of
R26R/lacZ activation (X-gal stain). Direct evidence of stabilization or knockout of b-catenin protein (FITC) in embryos with Pitx/Cre transgene and
either wt/wt, wt/loxEx3, or loxEx2–6/loxEx2–6 b-catenin genotypes is shown. Arrow indicates the caudal limit of nascent Rathke’s pouch and
Pitx/Cre activity. Ventral diencephalon (VD), Rathke’s pouch (RP).
(D) Coordinated expression of critical homeodomain factors (Hesx1, Prop1, and Pit1), Lef/Tcf factors (Tcf3, Tcf4, and Lef1), and Axin2 in pituitary
development. Cell types of the Pit1 lineage (light blue) express growth hormone (GH), prolactin (PRL), and thyroid-stimulating hormone (TSHb). Ventral
diencephalon (VD), Rathke’s pouch (RP), rostral tip (rt).Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc. 595
Figure 2. Wnt/b-Catenin Signaling Is Required for Pit1 Lineage Determination but Is Not Required for Cell-Type Differentiation
All histology panels are sagittal sections of embryonic pituitary except for (C).
(A) Smaller anterior gland (bracket) and caudal expansion of lumen in a pituitary with early conditional knockout for b-catenin.
(B) As assessed by in situ hybridization (specific signal is white), Pit1 is not expressed in early conditional knockout for b-catenin, but an epistatic
factor, Prop1, is expressed normally. Quantitative PCR analysis of Pit1 ratio is shown. Data are represented as mean ± SEM.
(C) Smaller anterior gland (bracket) in early conditional knockouts, with expression of aGSU, a marker for ventral cell types, and abundant cortico-
tropes (POMC) but loss of Pit1-dependent thyrotropes (TSHb) and somatotropes (GH).
(D) Gonadotropes, represented by expression of luteinizing hormone (LH), are still present, but Pit1-dependent lactotropes (PRL) are absent in early
conditional knockouts for b-catenin.
(E) Late conditional knockout of b-catenin following initial activation of Pit1 does not affect Pit1 autoregulation or cell differentiation.expression was completely absent in the mutants, based
on both in situ hybridization and qPCR analyses, whereas
expression of Prop1, an upstream regulator of Pit1, was
apparently not altered (Figure 2B). Hormone markers
for the three Pit1-dependent cell types—somatotropes
(GH), thyrotropes (TSHb), and lactotropes (PRL)—were
completely absent (Figures 2C and 2D) in the E17.5–P0
pituitary gland, consistent with the disappearance of
Pit1. The gonadotropes, represented by SF-1, aGSU,
and LHb, were still present, although in somewhat re-
duced numbers (Figure 2C and 2D and data not shown).
The corticotrope/melanotrope lineage, represented by
the lineage-determining factor T-Pit/Tbx19 and the hor-
mone POMC, appeared to be increased (Figure 2C and596 Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc.data not shown). No increased apoptosis was observed
from E9.5 to E13.5 (data not shown). These data suggest
that b-catenin activity is required for specific cell-lineage
determination in the anterior pituitary gland, functioning
epistatically to Pit1 activation, potentially in parallel to
Prop1.
In contrast to the dramatic consequence of b-catenin
deletion with Pitx1/Cre transgenic mice, deletion of b-cat-
enin specifically in the Pit1 lineage starting at E13.5 using
Pit1/Cre transgenic mice resulted in apparently normal
expression of Pit1 (Figure 2E), indicating that mainte-
nance of later Pit1 expression is independent of b-catenin
activity. Pituitary cell differentiation was not affected
in these mice as determined by expression of POMC,
Figure 3. Lef1 Is Not Required for Pit1
Expression and Pit1 Lineage Determina-
tion
(A) In early conditional knockouts for b-catenin,
Axin2 expression remains only in the rostral tip
(rt), and Lef1 is lost from both the intermediate
lobe (il) and caudomedial (cm) regions of the
anterior gland.
(B) Wild-type expression of Lef1 and Pit1 in ad-
jacent sections. At E13.5 or E14.5, Lef1 is
weaker and delayed relative to Pit1.
(C) In Lef1 knockout pituitaries, Pit1 expression
is upregulated but Prop1 is not changed.
(D) Loss of Lef1 leads to increased levels of Pit1
target genes (GH and TSHb) expressed by Pit1-
dependent thyrotropes and somatotropes,
while other cell types (POMC) are apparently
unchanged.
(E) ChIP analysis of E14.5 pituitaries, demon-
strating that Lef1 is recruited to the Pit1 early
enhancer (EE) but Tcf4 is not.
(F) Two-step ChIP in GHFT-1 cells with a-
AcK9H3, followed by either a-Prop1 or a-
Lef1. Prop1 is detected on the active endoge-
nous Pit1 early enhancer, while Lef1 is not
recruited.GH, aGSU, and TSHb (Figure 2E and data not shown).
Together, these temporally controlled loss-of-function ex-
periments (Figure 2) demonstrate that b-catenin in the de-
veloping pituitary functions specifically to initiatePit1 gene
expression but is not required for the subsequent terminal
differentiation events ofPit1 cell types. Indeed, during nor-
mal development, expression of Axin2 and Lef1, both indi-
cators of Wnt/b-catenin pathway activity, is diminished af-
ter E16.5 (Figure 1A).
Lef1/b-Catenin Does Not Induce Pit1 Expression
Consistent with their dependence on the Wnt/b-catenin
pathway for expression, neither Lef1 nor Axin2 was de-
tected in the caudomedial (Pit1-positive) field in Pitx1/
Cre early loss-of-function pituitary glands (Figure 3A).
However, rostral-tip expression of Axin2 persisted in mu-
tants, suggesting that independent mechanisms were re-
sponsible for its expression in this region (Figure 3A and
data not shown). Comparison of Pit1 and Lef1 expression
using adjacent sections from wild-type embryos revealed
that Pit1 became robustly expressed before Lef1 expres-
sion commenced. Furthermore, at E14.5, Lef1 expression
in the caudomedial domain of the anterior pituitary onlypartially overlapped the Pit1-expressing cell field
(Figure 3B), raising questions about any role of Lef1 in reg-
ulation of Pit1.
Indeed, in Lef1 gene-deleted mice (van Genderen et al.,
1994),Pit1 gene expression, as well asGH and TSHb gene
expression, was not reduced but, if anything, was elevated
(Figures 3C and 3D). Expression of other Lef/Tcf factors
was not altered in Lef1mutant pituitaries (data not shown).
We next examined the presence of Lef1 on the Pit1 gene
regulatory regions during development and found that, at
E14.5, Lef1 could be detected on the evolutionarily con-
served Pit1 early enhancer (EE), located at8 kb (Sornson
et al., 1996), but not on the late, autoregulatory enhancer
(LE) at 10.2 kb. (Figure 3E); Tcf4 was not detected, con-
sistent with the fact that it is not expressed at this time point
(Figure S1A). To investigate whether Lef1 was present on
the active or inactive Pit1 gene regulatory sequences, we
performed two-step chromatin immunoprecipitation. The
first step was performed with anti-Ac K9-H3 IgG and the
second step with either anti-Prop1 or anti-Lef1 IgGs
(Figure 3F). These studies revealed that Prop1, but not
Lef1, is present on the activated Pit1 early enhancer, as
marked by the presence of acetylated H3K9.Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc. 597
Thus, the expression of Lef1 actually somewhat attenu-
ates Pit1 gene expression, in contrast to the required
actions of b-catenin for inducing Pit1 expression. The
Lef1-related factors Tcf3/Tcf4 are poor candidates for
compensatory actions with Lef1 in negatively regulating
Pit1 because their expression domains are clearly non-
overlapping with Lef1 and Pit1 (Figure 1A and Figure 3B;
Figure S1A). More importantly, previous analysis of Tcf4
mutant mice revealed no change in the complement of
mature cell types at E18.5 but, instead, an increase in pitu-
itary size apparent at E14.5 (Brinkmeier et al., 2003).
Together, these observations raised the possibility that
Wnt/b-catenin might act in a Lef/Tcf-independent manner
to achieve Pit1 expression and cell-lineage determination
events.
A Prop1/b-Catenin Complex Is Required
to Induce Pit1 Expression
Therefore, the function of Prop1 in Pit1 gene activation
(Sornson et al., 1996) and its potential relationship with
the Wnt/b-catenin pathway was investigated. We gener-
ated mice in which the Prop1 gene was completely de-
leted and found that they fully recapitulated the essential
features of df (Nasonkin et al., 2004; Sornson et al.,
1996), including loss of Pit1-dependent cell types and
dysmorphogenesis of the anterior lobe (Figure 4A and
Figure S2). Lef1 was not observed at E13.5 and E14.5 in
the Prop1/ anterior gland, but it was still expressed in
the intermediate lobe (Figure 4A). Axin2 remained ex-
pressed in the ventral aspect of the lumen and in the ante-
rior lobe of Prop1/ pituitaries, indicating that some as-
pects of Wnt/b-catenin signaling remained intact in the
absence of Prop1 (Figure 4A).
To investigate potential genetic interactions between
Prop1 and b-catenin, we examined double-heterozygous
embryos generated by crossing Prop1+/ mice with con-
ditionally deleted b-catenin heterozygotes and observed
a consistently diminished expression of Pit1 in E14.5 dou-
ble-heterozygote embryos (Figure 4B), which provided ev-
idence that b-catenin and Prop1 function in the same ge-
netic pathway to activate Pit1 gene expression. These
genetic interactions were further supported by the obser-
vation of in vitro physical interactions between these two
proteins (Figure 4C). The C-terminal 60 aa of Prop1 inter-
acted robustly with the full-length b-catenin protein in
a GST pull-down protein-protein interaction assay (Fig-
ure 4C). The homeodomain of Prop1 was capable of
weaker interactions with b-catenin (Figure 4C). The b-cat-
enin domain was mapped using a series of overlapping
fragments, finding that a small region of b-catenin protein
consisting of armadillo repeat regions (5–9), correspond-
ing to the Lef/Tcf interaction domain (Graham et al.,
2000), was sufficient to mediate the interactions with
Prop1 (Figure 4C and data not shown). Together, these
genetic data demonstrate that b-catenin and Prop1 are
both required to regulate Pit1 gene expression. To estab-
lish that these interactions between Prop1 and b-catenin
holoproteins occur in a cellular context, we performed598 Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc.coimmunoprecipitation in GHFT-1 cells, as demonstrated
by a-b-catenin immunoblot of a-FLAG-Prop1 immunopre-
cipitate (Figure 4D). The recruitment of b-catenin to the
PrdQ (consensus Prop1 binding) site was analyzed using
an avidin-biotin complex DNA binding assay (ABCD)
(Glass et al., 1988). Biotinylated oligos containing 2 PrdQ
sites could specifically pull down b-catenin from HeLa
cells transfected with FLAG-Prop1 (Figure 4E).
We found that, in transiently transfected pituitary cell
lines in which the b-catenin pathway was stimulated,
Prop1 activated the 10 kb Pit1 promoter, which is suffi-
cient for Pit1 gene expression in transgenic mice (DiMattia
et al., 1997) (Figure 4F). In support of a direct functional re-
lationship between the b-catenin/Prop1 complex and Pit1
gene expression, single-cell nuclear microinjection assays
demonstrated the requirement for b-catenin in activation
of the early enhancer in the GHFT-1 pituitary cell line,
which expresses endogenous Pit1, but not Prop1 (Lew
et al., 1993 and data not shown). Prop1 activated the early
enhancer, and this activation was specifically blocked by
anti-b-catenin IgG or b-catenin siRNA (Figure 4G and
data not shown). As a control for functional specificity,
Pit1 actions on a Pit1 response element were b-catenin
independent and unaffected by anti-b-catenin IgG or
b-catenin siRNA (Figure 4H and data not shown). Syner-
gistic activation by Prop1 and b-catenin was found using
a minimal reporter construct under control of Prop1 regu-
latory elements (3 PrdQ) (Dasen et al., 2001; Sornson
et al., 1996) in HeLa cells that do not express Prop1.
(Figure 4I).
Consistent with the model that b-catenin is a required
coactivator for Prop1 (Figure 4J), as it is for Lef/Tcf, the
transcriptional activity of Prop1/b-catenin complex on
a PrdQ reporter was attenuated by overexpression of
the b-catenin inhibitors Chibby and ICAT (Tago et al.,
2000; Takemaru et al., 2003). Interestingly, cotransfection
of Lef1 with Prop1 and b-catenin expression vectors pro-
duced even stronger inhibition of PrdQ reporter activity
than Chibby or ICAT (Figure 4J). Lef1 was also capable
of attenuating Prop1/b-catenin-dependent activation of
a 10 kb Pit1 reporter (Figure 4K).
While the precise molecular mechanisms by which Lef1
diminishes Prop1/b-catenin-dependent Pit1 gene activa-
tion in vivo remain incompletely defined, we have ob-
served in cell culture that excess Lef1 can impair the
recruitment of Prop1 to its cognate PrdQ sites in a cotrans-
fection assay followed by chromatin immunoprecipitation
and qPCR (Figure 4L).
Coordinated Recruitment of Regulatory Complexes
to the Pit1 Gene Promoter and Enhancers
Based on the developmental role of Prop1/b-catenin,
analyses of factor/cofactor recruitment to regulatory re-
gions of the Pit1 gene (DiMattia et al., 1997; Rhodes
et al., 1993) by chromatin immunoprecipitation assay us-
ing microdissected embryonic pituitaries were performed.
These studies revealed that, at E11.5, the diMe K4-H3, tri-
MeK4-H3, and AcK9-H3 marks of activation were absent,
Figure 4. Prop/b-Catenin Interactions Acti-
vate the Pit1 Early Enhancer
(A) The Prop1 gene is required for anterior pituitary
expression ofPit1 and Lef1 in the caudomedial do-
main, but Lef1 is still expressed in the intermediate
lobe on E14.5–E15.0 (arrow), and Axin2 does not
require Prop1.
(B) Pituitaries doubly heterozygous for Prop1 and
b-catenin show a reduced domain of Pit1 expres-
sion.
(C) Left panel: Anti-FLAG Western blotting for bio-
chemical interactions between GST-Prop1 frag-
ments (homeodomain and carboxyl terminus) with
FLAG-tagged b-catenin. Right panel and lower
panel: High-affinity interactions with the Prop1 car-
boxyl terminus occur through b-catenin armadillo
repeats 5–9, similar to b-catenin/Lef1 interactions.
(D) Coimmunoprecipitation of FLAG-tagged Prop1
and b-catenin in GHFT-1 cells.
(E) Avidin-biotin complex DNA binding assay dem-
onstrating b-catenin binding to double-stranded
oligonucleotides containing the PrdQ consensus
Prop1 binding site.
(F) In transfected pituitary cells (TaT1 or aT3),
Prop1 and constitutively active b-catenin stimulate
a luciferase reporter gene with 10 kb of the Pit1
gene.
(G) In microinjected pituitary cells (GHFT-1), Prop1
activates a lacZ reporter gene regulated by
the 5/8.5 kb Pit1 early enhancer with a minimal
36 bp promoter from the prolactin gene, and Prop1
activation is blocked by coinjection of specific
antibody against b-catenin.
(H) As a control for antibody specificity, a reporter
gene with Pit1 binding sites is not blocked by coin-
jection of antibody against b-catenin (performed in
GHFT-1 cells that express endogenous Pit1).
(I) In transfected HeLa cells, Prop1 and active b-
catenin stimulate a luciferase reporter with three
paired-like homeodomain binding sites (PrdQ).
(J) Chibby and ICAT block activation of a Prop1/b-
catenin-dependent reporter in HeLa cells, as does
Lef1.
(K) Lef1 inhibits activation by Prop1/b-catenin of
a reporter gene regulated by 10 kb of the Pit1
gene enhancer/promoter in transfected pituitary
cells (GHFT-1).
(L) Expression of Lef1 decreases Prop1 recruitment
to the PrdQ reporter, as measured by quantitative
PCR readout of an a-Prop1 ChIP. Data are repre-
sented as mean ± SEM.Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc. 599
Figure 5. Coordinated Recruitment of
Regulatory Complexes to the Pit1 Gene
Promoter and Enhancers
Left: ChIP assay and PCR detection of protein/
chromatin interactions in microdissected em-
bryonic pituitary glands, showing temporally
ordered replacement of (A) transcriptional re-
pressors at E11.5, by (B) Prop1 at E12.5, and
(C) b-catenin at E13.5, in coordination with
the appearance of histone activation marks
(B–D). Right: Organization of the Pit1 gene pro-
moter and enhancers: 10.4 kb late enhancer,
5 to 8.5 kb early enhancer with paired-
like homeodomain DNA sites, and 0.327 kb
promoter.but diMe K9-H3 was present on Pit1 regulatory elements,
consistent with an active repression of thePit1 gene at this
time (Figure 5A and data not shown). At E11.5, the Pit1
early enhancer, which contains Prop1/Hesx1 homeodo-
main binding sites at8 kb (Sornson et al., 1996), was oc-
cupied by the Hesx1 repressor and TLE, but Prop1 was
not detected. By E12.5, the early enhancer was now occu-
pied by Prop1, with a small residue of TLE1 still detected.
However, there was no longer occupancy by Hesx1 at this
time, and a diMe K4-H3 mark was selectively present on
the early enhancer (Figure 5B). By E13.5, the early en-
hancer and promoter were co-occupied by both Prop1
and b-catenin, with full dismissal of TLEs (Figure 5C), co-
inciding with initial Pit1 gene activation. The diMe K4-H3,
triMe K4-H3, and Ac K9-H3 marks associated with active
promoters (Kouzarides, 2002) were also present
(Figure 5C and data not shown). In the adult, the Pit1
gene promoter harbored the histone marks of gene activa-
tion (triMe K4-H3 and Ac K9-H3), with diMe K4-H3 now
present on both the late and early enhancers (Figure 5D
and data not shown). This temporal progression of histone
modifications on regulatory regions of the Pit1 gene corre-
lates with the timing of b-catenin transcriptional activity
and Prop1 gene expression. Similarly, the loss of Hesx1
and TLE binding from E12.5 to E13.5 tracks the attenuated
expression of these factors preceding the induction of the
Pit1 gene (Dasen et al., 2001).
Wnt/b-Catenin Activity Inhibits Hesx1 Expression
Expression ofPit1and subsequent differentiation of soma-
totropes, thyrotropes, and lactotropes also depends on600 Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc.a concurrent attenuated expression of another paired-
like homeodomain transcription factor, Hesx1 (Dasen
et al., 2001). Maintaining transcriptional repression of tar-
gets of the Hesx1/TLE complex is important for early pitu-
itary development, and development of the organ can be
ablated in Hesx1/ embryos in specific genetic back-
grounds or when Hesx1-mediated repression is blocked
by ectopic expression of Prop1 from the Pitx1 promoter
(Dasen et al., 2001). Examination of the Hesx1 expression
pattern in Pitx1/Cre b-catenin gene deleted embryos by in
situ hybridization and qPCR revealed that Hesx1 expres-
sion persisted in the E14.5 anterior pituitary gland,
whereas expression was normally already diminished in
the wild-type littermates (Figure 6A). Hesx1 expression
was similarly extended in the Prop1 mutant embryos
(Gage et al., 1996; Sornson et al., 1996; data not shown),
suggesting the possibility that b-catenin and Prop1 to-
gether might subserve the inhibition of Hesx1 expression
at E11.5–E13.5.
Assessing the effects of premature activation of b-cate-
nin signaling on organ development by generating Pitx1/
Cre:CA-Cat mutants (early gain of function) revealed
that, while initial organ commitment was normal at E9.5,
there was complete absence of the gland in all mutants
examined by E13.5 (12/12) (Figure 6B). Lhx3, a marker
for the definitive Rathke’s pouch that is essential for pitu-
itary development, was initially expressed in the prospec-
tive Rathke’s pouch at E9.5 in both controls and gain-
of-function mutants (Figure 6C) but was not detected
in Rathke’s pouch of the b-catenin gain-of-function mu-
tant after E10.5 (Figure 6D), a phenotype similar to that
observed when Hesx1/TLE repression is absent (Dasen
et al., 2001). The canonical Wnt/b-catenin target genes
Axin2 and Lef1 were upregulated in E9.5 b-catenin gain-
of-function mutant embryos as expected (Figure 6E). Con-
sistent with the model that the Prop1/b-catenin complex
negatively regulates Hesx1 expression, we found that
Hesx1 was not expressed in E9.5 b-catenin gain-of-func-
tion mutants (Figure 6C).
A bioinformatic analysis of the mouse and human
Hesx1 regulatory sequences revealed several conserved
paired-like homeodomain binding sites (Figures 6F–6H).
Prop1 caused repression of reporters containing the con-
served regions encompassing the Prop1 binding sites in
transient transfection assays (Figure 6G). Chromatin im-
munoprecipitation of E12.5 pituitary glands demonstrated
the presence of both b-catenin and Prop1, but not Lef1,
on these conserved Hesx1 gene regulatory regions.
ChIP also revealed that HDAC1, TLEs, and Reptin were
also present with Prop1/b-catenin on the Hesx1 regula-
tory regions at E12.5 (Figure 6H). The functional signifi-
cance of these putative corepressors was confirmed by
use of single-cell nuclear microinjection of specific anti-
bodies (Figure 6I) or siRNAs (Figure 6J) against b-catenin,
HDACs, and TLEs, which reversed the repressive effects
of the Prop1/b-catenin complex on the Hesx1 regulatory
region. In contrast, aHDAC3 did not reverse repression.
Thus, in addition to the role of Prop1/b-catenin in acti-
vation of the Pit1 gene, our data suggest that the Prop1/
b-catenin complex simultaneously acts to repress
expression of Hesx1 at E12.5 via recruitment of specific
corepressor machinery, providing an essential regulatory
event required for the progression of normal pituitary
development.
DISCUSSION
A Novel DNA Binding Partner for b-Catenin
in Cell-Lineage Determination
In these studies, we have uncovered a novel transcrip-
tional strategy that underlies b-catenin control of cell-line-
age determination in organogenesis, revealing the unex-
pected role of a tissue-specific homeodomain factor as
the essential DNA binding transcription factor that recruits
b-catenin in mediating the actions of the Wnt/b-catenin
pathway, both for activation and for repression of specific
gene targets in pituitary development. In contrast to the
common Lef/Tcf factors that are the key DNA binding
partners mediating many other aspects of b-catenin activ-
ity, here we established genetically and biochemically that
b-catenin directly interacts with Prop1 and is a required
coregulator for Prop1 transcription activity, causing initial
activation of the cell-lineage-determining factor Pit1 at
E12.5–E13.5 and simultaneously directing repression of
the Hesx1 repressor (Figure 6K).
While some aspects of pituitary-gland proliferation are
regulated by Wnt4, Wnt5a, Pitx2, Aes1, and Tcf4 (Brink-
meier et al., 2003; Cha et al., 2004; Kioussi et al., 2002;
Treier et al., 1998), our findings suggest that other compo-nents of the Wnt signaling pathway serve as key signals for
lineage determination events by exerting both positive and
negative regulation on tissue-specific homeodomain fac-
tors. We find that Wnt/b-catenin signaling occurs in a spe-
cific developmental window between E11.5 and E14.5 of
pituitary development, where it is required for cell-type de-
termination as cells leave their niche in the lumen of
Rathke’s pouch. These events reflect a precise contextual
requirement for the b-catenin signal; if b-catenin is acti-
vated at E9.5, we find that Rathke’s pouch is completely
destroyed, apparently through perturbations of the en-
dogenous repression program mediated by Hesx1. Con-
versely, if the b-catenin signal is extended after initial
Pit1 lineage determination, terminal cell-type differentia-
tion events within the lineage are inhibited (unpublished
data).
Our finding that Prop1 is a key nuclear mediator for Wnt/
b-catenin signaling provides a molecular insight into the
mechanism by which Wnt signaling activity dictates cell-
lineage determination. In the skin, for example, b-catenin
has proven to be essential for the decision of hair-follicle
stem cells to adopt the epithelial or follicular fate
(Huelsken et al., 2001), apparently involving the actions
of Lef1 and Tcf3 (Merrill et al., 2001; van Genderen et al.,
1994; Zhou et al., 1995). In contrast to the skin, the nuclear
events downstream of Wnt/b-catenin in pituitary cell-line-
age determination are not primarily mediated via Tcf/Lef,
and our findings suggest that a subset of tissue-restricted
homeodomain factors (Kioussi et al., 2002), and undoubt-
edly other classes of transcription factors, will prove to
play key roles as DNA binding mediators of b-catenin sig-
naling in cell-fate decisions.
Our analyses have also revealed a transcriptional re-
pression function of the Prop1/b-catenin complex, impor-
tant in mediating cell-lineage determination based on
promoter-specific repression of Hesx1. This appears to
require a series of corepressors, including HDACs 1/2,
Reptin, and Groucho/TLEs. The selective participation of
Reptin as a component of b-catenin-mediated repression
is supported by its role in repression of Wingless signaling
in Drosophila (Bauer et al., 2000) and in suppression of
a metastasis suppressor gene in prostate cancer (Kim
et al., 2005).
Thus, investigation of the actions of b-catenin in cell-
lineage determination during pituitary organogenesis has
uncovered a simple molecular logic for promoting cell-
lineage determination, significantly differing from the
canonical Wnt/b-catenin pathway, based on the key role
of b-catenin as the promoter-specific coactivator or core-
pressor of a tissue-restricted DNA binding transcriptional
partner. It is likely that analogous molecular events func-
tion broadly in development and disease.
EXPERIMENTAL PROCEDURES
In Situ Hybridization
In situ hybridization was performed as described previously (Simmons
et al., 1990). The antisense in situ probe for Axin2 was a gift fromCell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc. 601
Figure 6. Prop1/b-Catenin Represses Hesx1 Repressor Expression
(A) Pitx1Cre/KO-Cat knockout pituitaries exhibit ectopic expression of Hesx1 (in situ hybridization signal is white) in the anterior gland (bracket), while
in wild-type littermates, Hesx1 is restricted dorsally or is extinguished. Quantitative PCR analysis of Hesx1 ratio is shown. Data are represented as
mean ± SEM.
(B) Hematoxylin-and-eosin-stained tissue sections, wherein early activation of b-catenin in Pitx1Cre/CA-Cat mutants ablates pituitary development
before E13.5. The arrow on the mutant panel indicates the presumptive location of the anterior pituitary (AP).
(C) Expression of Lhx3 is normal at E9.5, while Hesx1 is repressed in Pitx1Cre/CA-Cat mutants.
(D) Loss of Lhx3 expression in Pitx1Cre/CA-Cat E10.5 and 13.5 pituitaries.
(E) Wnt target genes Axin2 and Lef1 are induced in CA-Cat mutants.
(F) The Hesx1 50 enhancer (enh) contains conserved paired-like homeodomain sites.602 Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc.
Dr. Wei Hsu (University of Rochester). Probe templates for Lef/Tcf fac-
tors were generated by PCR for the following nucleotides: Tcf1 245–
1487 (NM_009331), Tcf3 356–1360 (NM_009332), Tcf4 212–1803
(NM_013865), Lef1 full-length 990–2183 (NM_010703), and Lef1 b-cat-
enin binding domain 701–1193 (NM_010703).
Generation and Analysis of Transgenic Animals
and Gene-Targeted Mice
Genotype analysis of b-catenin/loxP(ex2–6) and b-catenin/loxP(ex3)
mice (Brault et al., 2001; Harada et al., 1999), Lef1 mutant mice (van
Genderen et al., 1994), and generation of transgenic lines using Pitx1
and Pit1 promoters (Treier et al., 1998) have been described previ-
ously. Prop1+/;Pitx1CreKO- bCat+/ transheterozygotes were ob-
tained by crossing Prop1+/;Pitx1Cre mice with b-cateninex2–6/ex2–6
mice, and two controls and four transheterozygotes were processed
for analysis. Prop1 mutant mice were generated by targeted mutagen-
esis in ES cells to replace the entire coding sequence with a b-galac-
tosidase/neomycin selection cassette (Figure S2), and correct target-
ing was established by Southern blotting with 50 and 30 external
probes.
Transfection and Nuclear Microinjection Assays
Cotransfection experiments were performed as described previously
(Rhodes et al., 1993) in 293T and HeLa cells using 750 ng of luciferase
reporter, 100 ng of pCMX expression plasmids, and 500 ng of
pRSVbGal as an internal control for transfection efficiency. Transfec-
tions of pituitary cell lines used Fugene6 (Roche) instead of calcium
phosphate. The multimerized PrdQ/p36 luciferase reporter was de-
scribed previously (Sornson et al., 1996).
Chromatin Immunoprecipitation
Chromatin immunoprecipitations were performed as previously de-
scribed (Ju et al., 2004) on microdissected pituitaries, with a modified
fixation time of 30 min in 2% paraformaldehyde. Approximately 12
E13.5 pituitaries, 15 E12.5 pituitaries, 25 11.5 pituitaries, or 1 adult pi-
tuitary were used for each antibody. Anti-Prop1 antibody was gener-
ated in guinea pigs against bacterially expressed C0 of murine Prop1.
Rabbit anti-Reptin was a generous gift from Otmar Huber (Institute
of Clinical Chemistry and Pathobiochemistry, Berlin, Germany). Anti-
diMeK4H3 and triMeK4H3 were obtained from Upstate Biotechnol-
ogy, while anti-TLE, anti-Hesx1, anti-HDAC1, and anti-b-catenin
were from Santa Cruz Biotechnology. For sequence of ChIP primers,
see Supplemental Experimental Procedures.
Coimmunoprecipitation
HeLa cells were transfected with a FLAG-tagged Prop1 expression
vector (15 mg/10 cm plate); after 48 hr, the cells were harvested and nu-
clear extracts were prepared. Five hundred micrograms of nuclear ex-
tract was immunoprecipitated with 5 mg of either normal mouse IgG or
anti-FLAG antibody (Sigma). The Western blot was carried out with
goat anti-b-catenin antibody from Santa Cruz Biotechnology.GST-Affinity Purification and Protein Interaction Studies
GST-Prop1 homeodomain (amino acids 51–131) and GST-Prop1 C
terminus (aa 129–225) fusion proteins for protein interactions were
expressed in E. coli and purified from homogenized lysates with glu-
tathione-agarose beads at 25ºC for 1 hr. For interaction studies,
immobilized GST-fusion proteins were then mixed with 293T cell
lysates containing overexpressed, tagged b-catenin protein or 35S-
methionine labeled b-catenin protein fragments expressed in vitro
using reticulocyte lysates (Promega TnT Quick Coupled Transcrip-
tion/Translation System). Following SDS-PAGE and transfer to nitro-
cellulose, interacting proteins were visualized by Western blotting or
autoradiography. Isotope-labeled b-catenin fragments were N termi-
nus (aa 1–126), C terminus (aa 601–781), Arm repeats 1–4 (aa 121–
276), Arm repeats 5–9 (aa 270–483), and Arm repeats 10–12 (aa
477–713).
Avidin-Biotin Complex DNA Binding Assay
The ABCD assay was performed as described (Glass et al., 1988). See
Supplemental Experimental Procedures for details.
Quantitative PCR
Real-time PCR was performed on RNA extracted from wild-type and
b-catenin knockout embryonic pituitaries at E13.5 (Pit1) and 14.5
(Hesx1). The data were normalized to GAPDH and are presented as
fold change with respect to the wild-type. All experiments were per-
formed with two biological and two technical replicates. For oligo se-
quences, see Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, and two figures and can be found
with this article online at http://www.cell.com/cgi/content/full/125/3/
593/DC1/.
ACKNOWLEDGMENTS
We thank Janet Hightower and Marie Fisher for assistance with figure
and manuscript preparation, Havilah Taylor for help in maintaining the
mouse colony, Forrest Liu for help in generating Prop1 knockout mice,
and the UCSD transgenic core facility for assistance in generating
transgenic mice. L.E.O. and J.T. were supported by NIH training
grants, X.L. was supported by a Research Career Award NIDDK DK
064744, and M.G.R. is an investigator of the Howard Hughes Medical
Institute.
Received: July 30, 2005
Revised: December 13, 2005
Accepted: February 9, 2006
Published: May 4, 2006(G) In transfected GHFT-1 cells, Prop1 and b-catenin repress a luciferase reporter gene under control of the conserved Hesx1 50 enhancer and a het-
erologous thymidine kinase promoter. Data are represented as mean ± SEM.
(H) ChIP of the Hesx1 gene from microdissected E12.5 pituitaries, showing spatially localized interactions of Prop1, TLE, HDAC1, Reptin, and b-cat-
enin at the Hesx1 promoter and 50 enhancer at 0.5 kb but not a negative control region at 1.5 kb.
(I and J) Prop1 repression of Hesx1 promoter required b-catenin, Reptin, TLEs, HDAC1, and HDAC2, but not HDAC3, in a single-cell nuclear micro-
injection assay using specific antibodies (I) and gene-specific siRNAs (J). Data are represented as mean ± SEM.
(K) A model for Prop1 homeodomain-mediated nuclear events downstream of Wnt/b-catenin signaling on distinct sets of target genes. In response
to a Wnt signal received by pluripotent progenitor cells, stabilized b-catenin acts through direct interactions with the C terminus of Prop1 to activate
the Pit1 gene, a lineage-determining factor in pituitary development. Lineage determination is also achieved through the repressive actions of Prop1
and b-catenin, with recruitment of TLE, HDAC, and Reptin corepressors to silence Hesx1, which maintains cellular pluripotence and inhibits cell-fate
decisions.Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc. 603
REFERENCES
Aulehla, A., Wehrle, C., Brand-Saberi, B., Kemler, R., Gossler, A., Kan-
zler, B., and Herrmann, B.G. (2003). Wnt3a plays a major role in the
segmentation clock controlling somitogenesis. Dev. Cell 4, 395–406.
Barker, N., Hurlstone, A., Musisi, H., Miles, A., Bienz, M., and Clevers,
H. (2001). The chromatin remodelling factor Brg-1 interacts with beta-
catenin to promote target gene activation. EMBO J. 20, 4935–4943.
Bauer, A., Chauvet, S., Huber, O., Usseglio, F., Rothbacher, U., Ara-
gnol, D., Kemler, R., and Pradel, J. (2000). Pontin52 and reptin52 func-
tion as antagonistic regulators of beta-catenin signalling activity.
EMBO J. 19, 6121–6130.
Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Gross-
chedl, R., and Birchmeier, W. (1996). Functional interaction of beta-
catenin with the transcription factor LEF-1. Nature 382, 638–642.
Billin, A.N., Thirlwell, H., and Ayer, D.E. (2000). Beta-catenin-histone
deacetylase interactions regulate the transition of LEF1 from a tran-
scriptional repressor to an activator. Mol. Cell. Biol. 20, 6882–6890.
Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D.H., McMa-
hon, A.P., Sommer, L., Boussadia, O., and Kemler, R. (2001). Inactiva-
tion of the beta-catenin gene by Wnt1-Cre-mediated deletion results in
dramatic brain malformation and failure of craniofacial development.
Development 128, 1253–1264.
Brinkmeier, M.L., Potok, M.A., Cha, K.B., Gridley, T., Stifani, S., Meel-
dijk, J., Clevers, H., and Camper, S.A. (2003). TCF and Groucho-
related genes influence pituitary growth and development. Mol. Endo-
crinol. 17, 2152–2161.
Cadigan, K.M., and Nusse, R. (1997). Wnt signaling: a common theme
in animal development. Genes Dev. 11, 3286–3305.
Cavallo, R.A., Cox, R.T., Moline, M.M., Roose, J., Polevoy, G.A.,
Clevers, H., Peifer, M., and Bejsovec, A. (1998). Drosophila Tcf and
Groucho interact to repress Wingless signalling activity. Nature 395,
604–608.
Cha, K.B., Douglas, K.R., Potok, M.A., Liang, H., Jones, S.N., and
Camper, S.A. (2004). WNT5A signaling affects pituitary gland shape.
Mech. Dev. 121, 183–194.
Clevers, H., and van de Wetering, M. (1997). TCF/LEF factor earn their
wings. Trends Genet. 13, 485–489.
Daniels, D.L., and Weis, W.I. (2005). Beta-catenin directly displaces
Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription
activation. Nat. Struct. Mol. Biol. 12, 364–371.
Dasen, J.S., and Rosenfeld, M.G. (2001). Signaling and transcriptional
mechanisms in pituitary development. Annu. Rev. Neurosci. 24, 327–
355.
Dasen, J.S., Barbera, J.P., Herman, T.S., Connell, S.O., Olson, L., Ju,
B., Tollkuhn, J., Baek, S.H., Rose, D.W., and Rosenfeld, M.G. (2001).
Temporal regulation of a paired-like homeodomain repressor/TLE co-
repressor complex and a related activator is required for pituitary or-
ganogenesis. Genes Dev. 15, 3193–3207.
DiMattia, G.E., Rhodes, S.J., Krones, A., Carriere, C., O’Connell, S.,
Kalla, K., Arias, C., Sawchenko, P., and Rosenfeld, M.G. (1997). The
Pit1 gene is regulated by distinct early and late pituitary-specific en-
hancers. Dev. Biol. 182, 180–190.
Dorsky, R.I., Moon, R.T., and Raible, D.W. (1998). Control of neural
crest cell fate by the Wnt signalling pathway. Nature 396, 370–373.
Filali, M., Cheng, N., Abbott, D., Leontiev, V., and Engelhardt, J.F.
(2002). Wnt-3A/beta-catenin signaling induces transcription from the
LEF-1 promoter. J. Biol. Chem. 277, 33398–33410.
Gage, P.J., Brinkmeier, M.L., Scarlett, L.M., Knapp, L.T., Camper,
S.A., and Mahon, K.A. (1996). The Ames dwarf gene, df, is required
early in pituitary ontogeny for the extinction of Rpx transcription and
initiation of lineage-specific cell proliferation. Mol. Endocrinol. 10,
1570–1581.604 Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc.Giles, R.H., van Es, J.H., and Clevers, H. (2003). Caught up in a Wnt
storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1–24.
Glass, C.K., Holloway, J.M., Devary, O.V., and Rosenfeld, M.G. (1988).
The thyroid hormone receptor binds with opposite transcriptional ef-
fects to a common sequence motif in thyroid hormone and estrogen
response elements. Cell 54, 313–323.
Graham, T.A., Weaver, C., Mao, F., Kimelman, D., and Xu, W. (2000).
Crystal structure of a beta-catenin/Tcf complex. Cell 103, 885–896.
Harada, N., Tamai, Y., Ishikawa, T., Sauer, B., Takaku, K., Oshima, M.,
and Taketo, M.M. (1999). Intestinal polyposis in mice with a dominant
stable mutation of the beta-catenin gene. EMBO J. 18, 5931–5942.
Hari, L., Brault, V., Kleber, M., Lee, H.Y., Ille, F., Leimeroth, R., Para-
tore, C., Suter, U., Kemler, R., and Sommer, L. (2002). Lineage-specific
requirements of beta-catenin in neural crest development. J. Cell Biol.
159, 867–880.
Hecht, A., Vleminckx, K., Stemmler, M.P., van Roy, F., and Kemler, R.
(2000). The p300/CBP acetyltransferases function as transcriptional
coactivators of beta-catenin in vertebrates. EMBO J. 19, 1839–1850.
Hermesz, E., Mackem, S., and Mahon, K.A. (1996). Rpx: a novel ante-
rior-restricted homeobox gene progressively activated in the prechor-
dal plate, anterior neural plate and Rathke’s pouch of the mouse em-
bryo. Development 122, 41–52.
Hill, T.P., Spater, D., Taketo, M.M., Birchmeier, W., and Hartmann, C.
(2005). Canonical Wnt/beta-catenin signaling prevents osteoblasts
from differentiating into chondrocytes. Dev. Cell 8, 727–738.
Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G., and Birchmeier,
W. (2001). beta-Catenin controls hair follicle morphogenesis and
stem cell differentiation in the skin. Cell 105, 533–545.
Jho, E.H., Zhang, T., Domon, C., Joo, C.K., Freund, J.N., and Costan-
tini, F. (2002). Wnt/beta-catenin/Tcf signaling induces the transcription
of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol.
22, 1172–1183.
Ju, B.G., Solum, D., Song, E.J., Lee, K.J., Rose, D.W., Glass, C.K., and
Rosenfeld, M.G. (2004). Activating the PARP-1 sensor component
of the groucho/ TLE1 corepressor complex mediates a CaMKinase
IIdelta-dependent neurogenic gene activation pathway. Cell 119,
815–829.
Kim, J.H., Kim, B., Cai, L., Choi, H.J., Ohgi, K.A., Tran, C., Chen, C.,
Chung, C.H., Huber, O., Rose, D.W., et al. (2005). Transcriptional reg-
ulation of a metastasis suppressor gene by Tip60 and beta-catenin
complexes. Nature 434, 921–926.
Kioussi, C., Briata, P., Baek, S.H., Rose, D.W., Hamblet, N.S., Herman,
T., Ohgi, K.A., Lin, C., Gleiberman, A., Wang, J., et al. (2002). Identifi-
cation of a Wnt/Dvl/beta-Catenin / Pitx2 pathway mediating cell-
type-specific proliferation during development. Cell 111, 673–685.
Kleber, M., and Sommer, L. (2004). Wnt signaling and the regulation of
stem cell function. Curr. Opin. Cell Biol. 16, 681–687.
Kouzarides, T. (2002). Histone methylation in transcriptional control.
Curr. Opin. Genet. Dev. 12, 198–209.
Lee, H.Y., Kleber, M., Hari, L., Brault, V., Suter, U., Taketo, M.M., Kem-
ler, R., and Sommer, L. (2004). Instructive role of Wnt/beta-catenin in
sensory fate specification in neural crest stem cells. Science 303,
1020–1023.
Lew, D., Brady, H., Klausing, K., Yaginuma, K., Theill, L.E., Stauber, C.,
Karin, M., and Mellon, P.L. (1993). GHF-1-promoter-targeted immor-
talization of a somatotropic progenitor cell results in dwarfism in trans-
genic mice. Genes Dev. 7, 683–693.
Li, S., Crenshaw, E.B., 3rd, Rawson, E.J., Simmons, D.M., Swanson,
L.W., and Rosenfeld, M.G. (1990). Dwarf locus mutants lacking three
pituitary cell types result from mutations in the POU-domain gene
pit1. Nature 347, 528–533.
Logan, C.Y., and Nusse, R. (2004). The Wnt signaling pathway in devel-
opment and disease. Annu. Rev. Cell Dev. Biol. 20, 781–810.
Martinez-Barbera, J.P., Rodriguez, T.A., and Beddington, R.S. (2000).
The homeobox gene Hesx1 is required in the anterior neural ectoderm
for normal forebrain formation. Dev. Biol. 223, 422–430.
Merrill, B.J., Gat, U., DasGupta, R., and Fuchs, E. (2001). Tcf3 and Lef1
regulate lineage differentiation of multipotent stem cells in skin. Genes
Dev. 15, 1688–1705.
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Ma-
duro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers,
H. (1996). XTcf-3 transcription factor mediates beta-catenin-induced
axis formation in Xenopus embryos. Cell 86, 391–399.
Murtaugh, L.C., Law, A.C., Dor, Y., and Melton, D.A. (2005). Beta-cat-
enin is essential for pancreatic acinar but not islet development. Devel-
opment 132, 4663–4674.
Nasonkin, I.O., Ward, R.D., Raetzman, L.T., Seasholtz, A.F., Saunders,
T.L., Gillespie, P.J., and Camper, S.A. (2004). Pituitary hypoplasia and
respiratory distress syndrome in Prop1 knockout mice. Hum. Mol.
Genet. 13, 2727–2735.
Nelson, W.J., and Nusse, R. (2004). Convergence of Wnt, beta-cate-
nin, and cadherin pathways. Science 303, 1483–1487.
Peifer, M., and Polakis, P. (2000). Wnt signaling in oncogenesis and
embryogenesis—a look outside the nucleus. Science 287, 1606–1609.
Pinto, D., Gregorieff, A., Begthel, H., and Clevers, H. (2003). Canonical
Wnt signals are essential for homeostasis of the intestinal epithelium.
Genes Dev. 17, 1709–1713.
Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K.,
Hintz, L., Nusse, R., and Weissman, I.L. (2003). A role for Wnt signalling
in self-renewal of haematopoietic stem cells. Nature 423, 409–414.
Rhodes, S.J., Chen, R., DiMattia, G.E., Scully, K.M., Kalla, K.A., Lin,
S.C., Yu, V.C., and Rosenfeld, M.G. (1993). A tissue-specific enhancer
confers Pit1-dependent morphogen inducibility and autoregulation on
the pit1 gene. Genes Dev. 7, 913–932.
Scully, K.M., and Rosenfeld, M.G. (2002). Pituitary development: reg-
ulatory codes in mammalian organogenesis. Science 295, 2231–2235.
Simmons, D.M., Voss, J.W., Ingraham, H.A., Holloway, J.M., Broide,
R.S., Rosenfeld, M.G., and Swanson, L.W. (1990). Pituitary cell pheno-
types involve cell-specific Pit1 mRNA translation and synergistic
interactions with other classes of transcription factors. Genes Dev. 4,
695–711.
Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre
reporter strain. Nat. Genet. 21, 70–71.
Sornson, M.W., Wu, W., Dasen, J.S., Flynn, S.E., Norman, D.J.,
O’Connell, S.M., Gukovsky, I., Carriere, C., Ryan, A.K., Miller, A.P.,et al. (1996). Pituitary lineage determination by the Prophet of Pit1 ho-
meodomain factor defective in Ames dwarfism. Nature 384, 327–333.
Tago, K., Nakamura, T., Nishita, M., Hyodo, J., Nagai, S., Murata, Y.,
Adachi, S., Ohwada, S., Morishita, Y., Shibuya, H., and Akiyama, T.
(2000). Inhibition of Wnt signaling by ICAT, a novel beta-catenin-inter-
acting protein. Genes Dev. 14, 1741–1749.
Takemaru, K., Yamaguchi, S., Lee, Y.S., Zhang, Y., Carthew, R.W.,
and Moon, R.T. (2003). Chibby, a nuclear beta-catenin-associated
antagonist of the Wnt/Wingless pathway. Nature 422, 905–909.
Tao, Q., Yokota, C., Puck, H., Kofron, M., Birsoy, B., Yan, D., Asa-
shima, M., Wylie, C.C., Lin, X., and Heasman, J. (2005). Maternal
wnt11 activates the canonical wnt signaling pathway required for
axis formation in Xenopus embryos. Cell 120, 857–871.
Treier, M., Gleiberman, A.S., O’Connell, S.M., Szeto, D.P., McMahon,
J.A., McMahon, A.P., and Rosenfeld, M.G. (1998). Multistep signaling
requirements for pituitary organogenesis in vivo. Genes Dev. 12, 1691–
1704.
van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J.,
Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., et al. (1997).
Armadillo coactivates transcription driven by the product of the Dro-
sophila segment polarity gene dTCF. Cell 88, 789–799.
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I.,
Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis,
A.P., et al. (2002). The beta-catenin/TCF-4 complex imposes a
crypt progenitor phenotype on colorectal cancer cells. Cell 111,
241–250.
van Genderen, C., Okamura, R.M., Farinas, I., Quo, R.G., Parslow,
T.G., Bruhn, L., and Grosschedl, R. (1994). Development of several or-
gans that require inductive epithelial-mesenchymal interactions is im-
paired in LEF-1-deficient mice. Genes Dev. 8, 2691–2703.
Watkins-Chow, D.E., and Camper, S.A. (1998). How many homeobox
genes does it take to make a pituitary gland? Trends Genet. 14, 284–
290.
Zechner, D., Fujita, Y., Hulsken, J., Muller, T., Walther, I., Taketo, M.M.,
Crenshaw, E.B., 3rd, Birchmeier, W., and Birchmeier, C. (2003). beta-
Catenin signals regulate cell growth and the balance between progen-
itor cell expansion and differentiation in the nervous system. Dev. Biol.
258, 406–418.
Zhou, P., Byrne, C., Jacobs, J., and Fuchs, E. (1995). Lymphoid en-
hancer factor 1 directs hair follicle patterning and epithelial cell fate.
Genes Dev. 9, 700–713.Cell 125, 593–605, May 5, 2006 ª2006 Elsevier Inc. 605
